Perimeter Medical Imaging Stock Filter Stocks by Fundamentals
PINK Stock | CAD 0.50 0.06 10.71% |
Perimeter Medical Imaging fundamentals help investors to digest information that contributes to Perimeter Medical's financial success or failures. It also enables traders to predict the movement of Perimeter Stock. The fundamental analysis module provides a way to measure Perimeter Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Perimeter Medical stock.
Perimeter | Shares Owned by Institutions |
Perimeter Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Perimeter Medical from analyzing Perimeter Medical's financial statements. These drivers represent accounts that assess Perimeter Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Perimeter Medical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 2.7M | 72.1M | 180.9M | 73.3M | 78.9M | 82.8M | |
Enterprise Value | 15.7M | 62.5M | 176.6M | 45.2M | 65.1M | 32.8M |
Perimeter Fundamentals
Return On Equity | -0.77 | ||||
Return On Asset | -0.59 | ||||
Operating Margin | (20.51) % | ||||
Current Valuation | 40.94 M | ||||
Shares Outstanding | 93.38 M | ||||
Shares Owned By Insiders | 13.30 % | ||||
Shares Owned By Institutions | 33.22 % | ||||
Number Of Shares Shorted | 4.18 K | ||||
Price To Book | 3.00 X | ||||
Price To Sales | 76.37 X | ||||
Revenue | 544.64 K | ||||
Gross Profit | (738.51 K) | ||||
EBITDA | (21.44 M) | ||||
Net Income | (18.94 M) | ||||
Cash And Equivalents | 17.44 M | ||||
Cash Per Share | 0.39 X | ||||
Total Debt | 254.35 K | ||||
Debt To Equity | 0.02 % | ||||
Current Ratio | 11.92 X | ||||
Book Value Per Share | 0.23 X | ||||
Cash Flow From Operations | (19.84 M) | ||||
Short Ratio | 0.57 X | ||||
Earnings Per Share | (0.34) X | ||||
Target Price | 2.0 | ||||
Beta | 1.6 | ||||
Market Capitalization | 52.29 M | ||||
Total Asset | 27.09 M | ||||
Retained Earnings | (96.73 M) | ||||
Working Capital | 12.34 M | ||||
Net Asset | 27.09 M |
About Perimeter Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Perimeter Medical Imaging's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Perimeter Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Perimeter Medical Imaging based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Perimeter Stock Analysis
When running Perimeter Medical's price analysis, check to measure Perimeter Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perimeter Medical is operating at the current time. Most of Perimeter Medical's value examination focuses on studying past and present price action to predict the probability of Perimeter Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perimeter Medical's price. Additionally, you may evaluate how the addition of Perimeter Medical to your portfolios can decrease your overall portfolio volatility.